E-LIB Suche - Ergebnisse für: Haoran E

1

Utility of 18F-FDG PET/CT uptake values in predicting respo..:

Zhuang, Fenghui ; Haoran, E ; Huang, Jia...
Lung Cancer. 178 (2023) - p. 20-27 , 2023

Link: https://doi.org/10.1016/..

2

Proposal for Rib invasion as an independent T descriptor fo..:

Zhao, Mengmeng ; Wu, Junqi ; Deng, Jiajun...
Lung Cancer. 159 (2021) - p. 27-33 , 2021

Link: https://doi.org/10.1016/..

3

Perioperative outcomes comparison of robotic and video-assi..:

E, Haoran ; Yang, Chenlu ; Zhang, Lei...
Updates in Surgery. , 2023

Link: https://doi.org/10.1007/..

4

Clinical utility of [18F]FDG PET/CT in the assessment of me..:

Zhang, Lei ; E, Haoran ; Huang, Jia...
European Radiology. 33 (2023) 12 - p. 8564-8572 , 2023

Link: https://doi.org/10.1007/..

5

The IASLC grading system for invasive pulmonary adenocarcin..:

E, Haoran ; Wu, Junqi ; Ren, Yijiu...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. 175883592211480 , 2023

Link: https://doi.org/10.1177/..

6

The additional radiotherapy to adjuvant chemotherapy improv..:

Guo, Jianbo ; Zhang, Lei ; Zhang, Liping...
Journal of Cancer Research and Clinical Oncology. 149 (2023) 14 - p. 13311-13321 , 2023

Link: https://doi.org/10.1007/..

7

Major pathological response exhibited distinct prognostic s..:

Xia, Lang ; Guo, Junhong ; E, Haoran...
Histopathology. 82 (2023) 5 - p. 691-703 , 2023

Link: https://doi.org/10.1111/..

8

Reconsidering T component of cancer staging for T3/T4 non-s..:

Wang, Fang ; Su, Hang ; E, Haoran...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211305 , 2022

Link: https://doi.org/10.1177/..

9

The predictive value of inflammatory biomarkers for major p..:

Li, Chongwu ; Wu, Junqi ; Jiang, Long...
Cancer Immunology, Immunotherapy. 72 (2022) 3 - p. 783-794 , 2022

Link: https://doi.org/10.1007/..

10

Correction to: The predictive value of inflammatory biomark..:

Li, Chongwu ; Wu, Junqi ; Jiang, Long...
Cancer Immunology, Immunotherapy. 72 (2022) 3 - p. 795-795 , 2022

Link: https://doi.org/10.1007/..

11

Real-world clinical outcomes of neoadjuvant immunotherapy c..:

Wu, Junqi ; Hou, Likun ; E, Haoran...
Lung Cancer. 165 (2022) - p. 115-123 , 2022

Link: https://doi.org/10.1016/..

12

A modified T categorization for part-solid lesions in Chine..:

Deng, Jiajun ; Zhao, Mengmeng ; Wang, Tingting...
Lung Cancer. 145 (2020) - p. 33-39 , 2020

Link: https://doi.org/10.1016/..

13

The IASLC grading system for invasive pulmonary adenocarcin..:

Haoran E ; Junqi Wu ; Yijiu Ren...
https://doi.org/10.1177/17588359221148028. , 2023

Link: https://doi.org/10.1177/..

14

Reconsidering T component of cancer staging for T3/T4 non-s..:

Fang Wang ; Hang Su ; Haoran E...
https://doi.org/10.1177/17588359221130502. , 2022

Link: https://doi.org/10.1177/..

15

sj-docx-1-tam-10.1177_17588359221148028 – Supplemental mate..:

Haoran E (13996842) ; Junqi Wu (9552791) ; Yijiu Ren (6599108)...
https://figshare.com/articles/journal_contribution/sj-docx-1-tam-10_1177_17588359221148028_Supplemental_material_for_The_IASLC_grading_system_for_invasive_pulmonary_adenocarcinoma_a_potential_prognosticator_for_patients_receiving_neoadjuvant_therapy/21875101. , 2023

Link: https://doi.org/10.25384..